Gilead Sciences Inc (NASDAQ:GILD)

During the Trading Day
107.51 +0.10 / +0.09%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
107.86 +0.35 / +0.33%
 
Volume: 114.4K
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$162.4B

Company Description

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. Its primary areas of focus include human immunodeficiency virus/AIDS, liver diseases such as hepatitis B virus and hepatitis C virus, serious cardiovascular/metabolic and respiratory conditions. Gilead Sciences was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

Contact Information

Gilead Sciences, Inc.
333 Lakeside Drive
Foster City California 94404
P:(650) 574-3000
Investor Relations:
(650) 522-5643

Employees

Shareholders

Mutual fund holders55.97%
Other institutional36.72%
Individual stakeholders1.02%

Top Executives

John C. MartinChairman & Chief Executive Officer
John F. MilliganPresident & Chief Operating Officer
Robin L. WashingtonChief Financial Officer & Executive Vice President
Norbert W. BischofbergerChief Scientific Officer & Executive VP-Research
Gregg H. AltonSecretary, EVP-Corporate & Medical Affairs

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.